# reload+after+2024-01-20 06:46:19.932851
address1§One Kendall Square
address2§4th Floor Suite B14402 Building 1400 West
city§Cambridge
state§MA
zip§02139
country§United States
phone§617 863 5500
website§https://www.invivotherapeutics.com
industry§Biotechnology
sector§Healthcare
longBusinessSummary§InVivo Therapeutics Holdings Corp. operates as a research and clinical-stage biomaterials and biotechnology company in the United States. The company engages in developing and commercializing biopolymer scaffolding devices for the treatment of spinal cord injuries (SCI). It is developing a Neuro-Spinal Scaffold implant comprise of biocompatible and bioresorbable polymers, which includes Poly lactic-co-glycolic acid, a polymer which is widely used in resorbable sutures and provides the biocompatible support for Neuro-Spinal Scaffold implant; and Poly-L-Lysine, a positively charged polymer used to coat surfaces to promote cellular attachment. The company was incorporated in 2003 and is headquartered in Cambridge, Massachusetts.
fullTimeEmployees§6
companyOfficers§[{'maxAge': 1, 'name': 'Dr. Richard M. Toselli M.D.', 'age': 65, 'title': 'President, CEO, Chief Medical Officer & Director', 'yearBorn': 1958, 'fiscalYear': 2022, 'totalPay': 825204, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Richard C. Christopher', 'age': 53, 'title': 'CFO & Treasurer', 'yearBorn': 1970, 'fiscalYear': 2022, 'totalPay': 537816, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Ms. Heather M. Hamel J.D.', 'age': 33, 'title': 'Chief Legal Officer & General Counsel', 'yearBorn': 1990, 'fiscalYear': 2022, 'totalPay': 446957, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Dr. Robert S. Langer Jr., Ph.D.', 'age': 74, 'title': 'Co-Founder & Member of Scientific Advisory Board', 'yearBorn': 1949, 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Dr. Joseph Philip Vacanti M.D.', 'age': 74, 'title': 'Co-Founder', 'yearBorn': 1949, 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}]
compensationAsOfEpochDate§1672444800
maxAge§86400
priceHint§4
payoutRatio§0.0
beta§0.723
currency§USD
dateShortInterest§1702598400
forwardEps§-10.8
exchange§NCM
quoteType§EQUITY
shortName§InVivo Therapeutics Holdings Co
longName§InVivo Therapeutics Holdings Corp.
firstTradeDateEpochUtc§1289831400
timeZoneFullName§America/New_York
timeZoneShortName§EST
uuid§672db550-c94d-3efd-a20d-c75b136c2372
gmtOffSetMilliseconds§-18000000
recommendationKey§none
quickRatio§12.884
grossMargins§0.0
ebitdaMargins§0.0
trailingPegRatio§None
